Evolent Health, Inc. (EVH)
NYSE · Healthcare · Health Information Services
$3.61+4.34%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $408M
- Forward P/E
- 8.9
- 52-week range
- $2.10 – $8.46
- 52-week change
- −58.06%
- EPS (trailing)
- −$4.49
- Analyst rating
- 1.7 Buy
- Next earnings
- Nov 5, 2026
Fiscal year to Dec 2025
- Revenue
- $1.9B (−26.56%)
- Net income
- −$579M
- Operating margin
- −21.9%
- Diluted EPS
- −$5.07
From the company’s annual report on SEC EDGAR.
About Evolent Health, Inc.
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Headquarters: Arlington, United States · 4,200 employees · evolent.com